Impact of circulating tumor DNA early detection and serial monitoring in the management of stage I to III colorectal cancer

Por Bello Roufai, Diana, Bidard, François-Clément
Publicado no Ann Transl Med (2019)

Circulating tumor cells in breast cancer

Por Bidard, Francois-Clement, Proudhon, Charlotte, Pierga, Jean-Yves
Publicado no Mol Oncol (2016)

A "class action" against the microenvironment: do cancer cells cooperate in metastasis?

Por Bidard, François-Clément, Pierga, Jean-Yves, Vincent-Salomon, Anne, Poupon, Marie-France
Publicado em 2008

ESR1 Mutation Detection and Dynamics in Meningeal Carcinomatosis in Breast Cancer

Por Carausu, Marcela, Melaabi, Samia, Pierga, Jean-Yves, Bidard, François-Clément, Cabel, Luc
Publicado no J Breast Cancer (2019)

Cdk4/6 inhibitors and overall survival: power of first-line trials in metastatic breast cancer

Por Tanguy, Marie-Laure, Cabel, Luc, Berger, Fréderique, Pierga, Jean-Yves, Savignoni, Alexia, Bidard, Francois-Clement
Publicado no NPJ Breast Cancer (2018)

Circulating Tumor Cells in Early Breast Cancer

Por Thery, Laura, Meddis, Alessandra, Cabel, Luc, Proudhon, Charlotte, Latouche, Aurelien, Pierga, Jean-Yves, Bidard, Francois-Clement
Publicado no JNCI Cancer Spectr (2019)

HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer

Por Nanou, Afroditi, Zeune, Leonie Laura, Bidard, Francois-Clement, Pierga, Jean-Yves, Terstappen, Leonardus Wendelinus Mathias Marie
Publicado no Breast Cancer Res (2020)

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions

Por Decraene, Charles, Bortolini Silveira, Amanda, Michel, Marc, Bidard, François-Clément, Pierga, Jean-Yves, Stern, Marc-Henri, Proudhon, Charlotte
Publicado no J Vis Exp (2018)

Radiation myelitis after pembrolizumab administration, with favorable clinical evolution and safe rechallenge: a case report and review of the literature

Por Carausu, Marcela, Beddok, Arnaud, Langer, Adriana, Girard, Nicolas, Bidard, François-Clément, Massiani, Marie-Ange, Ricard, Damien, Cabel, Luc
Publicado no J Immunother Cancer (2019)

Endothelial follicle-stimulating hormone receptor expression in invasive breast cancer and vascular remodeling at tumor periphery

Por Planeix, François, Siraj, Mohammad-Ahsan, Bidard, François-Clément, Robin, Blaise, Pichon, Christophe, Sastre-Garau, Xavier, Antoine, Martine, Ghinea, Nicolae
Publicado no J Exp Clin Cancer Res (2015)

Predictive performance of microarray gene signatures: impact of tumor heterogeneity and multiple mechanisms of drug resistance

Por Ng, Charlotte K. Y., Weigelt, Britta, A’Hern, Roger, Bidard, Francois-Clement, Lemetre, Christophe, Swanton, Charles, Shen, Ronglai, Reis-Filho, Jorge S.
Publicado em 2014

Impact de l’épidémie de COVID-19 sur les demandes de prise en charge initiale pour cancer du sein

Por Héquet, Delphine, Rodrigues, Manuel, Tardivon, Anne, Langer, Adriana, Dahan, Meryl, Rouzier, Roman, Takanen, Silvia, Kirova, Yulia, Bidard, François-Clément, Cottu, Paul
Publicado no Bull Cancer (2020)

Circulating Tumor Cells and Bevacizumab Pharmacokinetics during Neoadjuvant Treatment Combining Chemotherapy and Bevacizumab for Early Breast Cancer: Ancillary Analysis of the AVAS...

Por Sabatier, Renaud, Pierga, Jean-Yves, Curé, Hervé, Abulnaja, Rakan, Lambaudie, Eric, Bidard, François-Clément, Extra, Jean-Marc, Sfumato, Patrick, Gonçalves, Anthony
Publicado no Cancers (Basel) (2021)

Establishment and validation of circulating tumor cell-based prognostic nomograms in first-line metastatic breast cancer patients

Por Giordano, Antonio, Egleston, Brian L., Hajage, David, Bland, Joseph, Hortobagyi, Gabriel N., Reuben, James M., Pierga, Jean-Yves, Cristofanilli, Massimo, Bidard, Francois-Clement
Publicado em 2013

Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study

Por Bidard, François-Clément, Hajage, David, Bachelot, Thomas, Delaloge, Suzette, Brain, Etienne, Campone, Mario, Cottu, Paul, Beuzeboc, Philippe, Rolland, Emilie, Mathiot, Claire, Pierga, Jean-Yves
Publicado em 2012

Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study

Por Bidard, François-Clément, Belin, Lisa, Delaloge, Suzette, Lerebours, Florence, Ngo, Charlotte, Reyal, Fabien, Alran, Séverine, Giacchetti, Sylvie, Marty, Michel, Lebofsky, Ronald, Pierga, Jean-Yves
Publicado em 2013

A three dimensional thermoplastic microfluidic chip for robust cell capture and high resolution imaging

Por Mottet, Guillaume, Perez-Toralla, Karla, Tulukcuoglu, Ezgi, Bidard, Francois-Clement, Pierga, Jean-Yves, Draskovic, Irena, Londono-Vallejo, Arturo, Descroix, Stephanie, Malaquin, Laurent, Louis Viovy, Jean
Publicado em 2014

Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival

Por Rochefort, Pauline, Chabaud, Sylvie, Pierga, Jean-Yves, Tredan, Olivier, Brain, Etienne, Bidard, François-Clément, Schiffler, Camille, Polena, Helena, Khalil-Mgharbel, Abir, Vilgrain, Isabelle, Bachelot, Thomas
Publicado no Br J Cancer (2017)

Quantitative CT Extent of Lung Damage in COVID-19 Pneumonia Is an Independent Risk Factor for Inpatient Mortality in a Population of Cancer Patients: A Prospective Study

Por Ramtohul, Toulsie, Cabel, Luc, Paoletti, Xavier, Chiche, Laurent, Moreau, Pauline, Noret, Aurélien, Vuagnat, Perrine, Cherel, Pascal, Tardivon, Anne, Cottu, Paul, Bidard, François-Clément, Servois, Vincent
Publicado no Front Oncol (2020)

Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma

Por Piperno-Neumann, Sophie, Diallo, Alhassane, Etienne-Grimaldi, Marie-Christine, Bidard, François-Clément, Rodrigues, Manuel, Plancher, Corine, Mariani, Pascale, Cassoux, Nathalie, Decaudin, Didier, Asselain, Bernard, Servois, Vincent
Publicado no Oncologist (2016)